a decreasing trendp=0.41
In addition, severe adverse events (≥grade IIIb according to the Clavien-Dindo classification) did not increase and showed a decreasing trend (1.2 vs 0.9 per month, p=0.41).
In addition, severe adverse events (≥grade IIIb according to the Clavien-Dindo classification) did not increase and showed a decreasing trend (1.2 vs 0.9 per month, p=0.41).